zalcitabine has been researched along with Nervous System Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, TD; Arezzo, J; Brosnan, C; Calderon, RO; Davidovich, A; DeVries, GH; DeVries, JT; Feldman, D; Fossom, LH; Sprinkle, TJ | 1 |
| Blum, AS; Cornblath, DR; Dal Pan, GJ; Feinberg, J; Mayjo, K; McArthur, JC; Raines, C | 1 |
| Gilden, D | 1 |
1 trial(s) available for zalcitabine and Nervous System Disorders
| Article | Year |
|---|---|
Low-dose zalcitabine-related toxic neuropathy: frequency, natural history, and risk factors.
Topics: Adult; Cohort Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; HIV Seropositivity; Humans; Incidence; Male; Middle Aged; Nervous System Diseases; Risk Factors; Sensation Disorders; Survival Analysis; Zalcitabine | 1996 |
2 other study(ies) available for zalcitabine and Nervous System Disorders
| Article | Year |
|---|---|
Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
Topics: Animals; Axons; Electrophysiology; Female; Ganglia, Spinal; Humans; Male; Microscopy, Electron; Mitochondria; Mitochondria, Muscle; Myelin P0 Protein; Myelin Proteins; Myelin Sheath; Nerve Fibers; Nerve Tissue Proteins; Nervous System Diseases; Neural Conduction; Neurons; Peroneal Nerve; Phospholipids; Rabbits; Reference Values; RNA, Messenger; Schwann Cells; Sciatic Nerve; Time Factors; Zalcitabine | 1994 |
Treatment briefs.
Topics: CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Industry; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Nerve Growth Factors; Nervous System Diseases; Pyridines; Recombinant Proteins; Stavudine; Zalcitabine; Zidovudine | 1995 |